Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Amy E. Herr, Ph.D. to serve as an independent director on the Company's Board of Directors beginning on February 1, 2025. Dr.

Bay Area members of Congress blasted incursions by Elon Musk’s team into government’s sensitive data and systems.

According to DelveInsight’s epidemiology model, the total diagnosed prevalent cases of Parkinson’s disease were approximately ...

Corporation (NASDAQ: TECH), a global life sciences company valued at $11.45 billion, has announced the appointment of Dr. Amy E. Herr as an independent director on its Board of Directors. Dr. Herr ...

Using a servo-controlled truss, a unique 3D surface can dynamically transition between absorption, reflection, and ...

The Elon Musk-led Department of Government Efficiency (DOGE) has come under scrutiny for hiring several young engineers, including Indian-origin Akash Bobba, despite their minimal experience in ...

It also is exactly the type of story that Darren Cooke, the interim chief innovation and entrepreneurship officer at UC Berkeley ... part of Tuesday's Berkeley Bio Startup Showcase.

also partnered with UCB – and felzartamab, an anti-CD38 antibody for IgA nephropathy (IgAN) and other diseases, licensed from Human Immunology Biosciences (HI-Bio) for $1.15 billion upfront ...

Today, we're tracking presentations from AbbVie, UCB, WuXi AppTec and several other ... The corporate update came shortly after Samsung Bio revealed its largest production contract in company ...

One of the final events of Stan State’s Black History Month commemoration is a celebration of the 100th anniversary of the ...